Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Rajkumar

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Leukemia|October 22, 2015
Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myelomaG P Kaufman, M A Gertz, A Dispenzieri, et al.
Blood Cancer Journal|June 17, 2017
Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myelomaP Ravi, S Kumar, W Gonsalves, et al.
Leukemia|September 5, 2012
Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myelomaA J Greenberg, A M Lee, D J Serie, et al.
Kidney International|April 4, 2008
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chainsN Leung, M A Gertz, S R Zeldenrust, et al.
Leukemia|January 21, 2014
Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination SurveyO Landgren, B I Graubard, J A Katzmann, et al.
Blood Cancer Journal|July 30, 2016
Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myelomaP Ravi, S Kumar, J T Larsen, et al.
Leukemia|February 20, 2003
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myelomaC S Debes-Marun, G W Dewald, S Bryant, et al.
Blood Cancer Journal|March 21, 2015
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myelomaW I Gonsalves, N Leung, S V Rajkumar, et al.
Leukemia|October 4, 2012
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative projectH Avet-Loiseau, B G M Durie, M Cavo, et al.
Blood Cancer Journal|August 26, 2017
Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working GroupJ Hillengass, L A Moulopoulos, S Delorme, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Leukemia|October 22, 2015
Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myelomaG P Kaufman, M A Gertz, A Dispenzieri, et al.
Blood Cancer Journal|June 17, 2017
Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myelomaP Ravi, S Kumar, W Gonsalves, et al.
Leukemia|September 5, 2012
Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myelomaA J Greenberg, A M Lee, D J Serie, et al.
Kidney International|April 4, 2008
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chainsN Leung, M A Gertz, S R Zeldenrust, et al.
Leukemia|January 21, 2014
Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination SurveyO Landgren, B I Graubard, J A Katzmann, et al.
Blood Cancer Journal|July 30, 2016
Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myelomaP Ravi, S Kumar, J T Larsen, et al.
Leukemia|February 20, 2003
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myelomaC S Debes-Marun, G W Dewald, S Bryant, et al.
Blood Cancer Journal|March 21, 2015
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myelomaW I Gonsalves, N Leung, S V Rajkumar, et al.
Leukemia|October 4, 2012
Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative projectH Avet-Loiseau, B G M Durie, M Cavo, et al.
Blood Cancer Journal|August 26, 2017
Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working GroupJ Hillengass, L A Moulopoulos, S Delorme, et al.
Pageof 18